DSP Healthcare Fund - Regular Plan - Growth
Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 05-11-2018
AUM:
₹ 2,343.94 Cr
Expense Ratio
2.0%
Benchmark
S&P BSE Healthcare TRI
ISIN
INF740KA1LD8
Minimum Investment
100.0
Minimum Topup
100.0
Minimum SIP Amount
500
Fund Manager
Jay Kothari, Chirag Dagli
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| DSP Healthcare Fund - Regular Plan - Growth | 49.16 | 16.22 | 27.19 |
| S&P BSE Healthcare TRI | 52.62 | 13.64 | 22.27 |
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
32.751
Last change
0.26 (0.7908%)
Fund Size (AUM)
₹ 2,343.94 Cr
Performance
24.22% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
Fund Manager
Jay Kothari, Chirag Dagli
Riskometer
Very High
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| Sun Pharmaceutical Industries Ltd. | 13.06 |
| Ipca Laboratories Ltd. | 9.17 |
| Suven Pharmaceuticals Ltd. | 8.15 |
| Cipla Ltd. | 7.67 |
| Lupin Ltd. | 7.67 |
| Alembic Pharmaceuticals Ltd. | 6.07 |
| Apollo Hospitals Enterprise Ltd. | 4.72 |
| Concord Biotech Ltd. | 4.44 |
| Zydus Lifesciences Ltd. | 4.22 |
| Globus Medical Inc | 3.94 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Healthcare | 96.3 |
| Insurance | 1.76 |
| Others | 1.03 |
| Financial | 0.91 |
Peer Comparison
| Scheme Name | 5Y (%) |
|---|---|
| DSP Healthcare Reg Gr | 27.19 |
| ICICI Pru Pharma Healthcare and Diagnostics PHD Fund Cum | 25.77 |
| ABSL Pharma and Healthcare Reg Gr | 0.0 |
| Tata India Pharma & Healthcare Reg Gr | 23.56 |
| SBI HEALTHCARE Opportunities Reg Gr | 24.87 |
| Nippon India Pharma Fund Gr Gr | 24.41 |
| UTI Healthcare Reg Gr | 22.44 |
| Mirae Asset Healthcare Reg Gr | 25.04 |
| LIC MF Healthcare Fund Reg Gr | 19.52 |
| ITI Pharma and Healthcare Fund Reg Gr | 0.0 |